Autophagy genes are required for normal lipid levels in C. elegans

被引:59
|
作者
Lapierre, Louis R. [1 ]
Silvestrini, Melissa J. [2 ,4 ]
Nunez, Lizbeth [2 ]
Ames, Kristina [2 ,4 ]
Wong, Sara [2 ]
Le, Thuc T. [3 ]
Hansen, Malene [1 ]
Melendez, Alicia [2 ,4 ]
机构
[1] Sanford Burnham Med Res Inst, Del E Webb Neurosci Aging & Stem Cell Res Ctr, Program Dev & Aging, La Jolla, CA USA
[2] CUNY Queens Coll, Dept Biol, Flushing, NY 11367 USA
[3] Nevada Canc Inst, Dept Drug Target & Discovery, Las Vegas, NV USA
[4] CUNY, Grad Ctr, New York, NY USA
基金
美国国家科学基金会;
关键词
autophagy; fat storage; lipid metabolism; intestine; Oil-Red-O staining; CARS microscopy; C; elegans; J-DOMAIN PROTEIN; LIFE-SPAN; RETROGRADE TRANSPORT; FAT; METABOLISM; LONGEVITY; EXTENSION; REVEALS; PATHWAY; STORAGE;
D O I
10.4161/auto.22930
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Autophagy is a cellular catabolic process in which various cytosolic components are degraded. For example, autophagy can mediate lipolysis of neutral lipid droplets. In contrast, we here report that autophagy is required to facilitate normal levels of neutral lipids in C. elegans. Specifically, by using multiple methods to detect lipid droplets including CARS microscopy, we observed that mutants in the gene bec-1 (VPS30/ATG6/BECN1), a key regulator of autophagy, failed to store substantial neutral lipids in their intestines during development. Moreover, loss of bec-1 resulted in a decline in lipid levels in daf-2 [insulin/IGF-1 receptor (IIR) ortholog] mutants and in germline-less glp-1/Notch animals, both previously recognized to accumulate neutral lipids and have increased autophagy levels. Similarly, inhibition of additional autophagy genes, including unc-51/ULK1/ATG1 and lgg-1/ATG8/MAP1LC3A/LC3 during development, led to a reduction in lipid content. Importantly, the decrease in fat accumulation observed in animals with reduced autophagy did not appear to be due to a change in food uptake or defecation. Taken together, these observations suggest a broader role for autophagy in lipid remodeling in C. elegans.
引用
收藏
页码:278 / 286
页数:9
相关论文
共 50 条
  • [41] Analysis of putative olfactory receptor genes in C. elegans
    Kiriyama, Keisuke
    Hirotsu, Takaaki
    Kamizaki, Tomoko
    Satou, Noriko
    Ishihara, Takeshi
    NEUROSCIENCE RESEARCH, 2009, 65 : S175 - S175
  • [42] From genes to function: the C. elegans genetic toolbox
    Boulin, Thomas
    Hobert, Oliver
    WILEY INTERDISCIPLINARY REVIEWS-DEVELOPMENTAL BIOLOGY, 2012, 1 (01) : 114 - 137
  • [43] OrthoList: A Compendium of C. elegans Genes with Human Orthologs
    Shaye, Daniel D.
    Greenwald, Iva
    PLOS ONE, 2011, 6 (05):
  • [44] Long-term memory genes in C. elegans
    Brooke LaFlamme
    Nature Genetics, 2015, 47 (3) : 198 - 198
  • [45] Analyses of Alternative Splicing in C. elegans Longevity Genes
    Seipelt, Rebecca
    Saites, Louis
    Mohan, Varuna
    Winfrey, Alexander
    FASEB JOURNAL, 2010, 24
  • [46] Clustered organization of reproductive genes in the C. elegans genome
    Miller, MA
    Cutter, AD
    Yamamoto, I
    Ward, S
    Greenstein, D
    CURRENT BIOLOGY, 2004, 14 (14) : 1284 - 1290
  • [47] Promoter trapping identifies real genes in C. elegans
    I. A. Hope
    J. M. Arnold
    D. McCarroll
    G. Jun
    A. P. Krupa
    R. Herbert
    Molecular and General Genetics MGG, 1998, 260 : 300 - 308
  • [48] Genes in human obesity loci are causal obesity genes in C. elegans
    Ke, Wenfan
    Reed, Jordan N.
    Yang, Chenyu
    Higgason, Noel
    Rayyan, Leila
    Waehlby, Carolina
    Carpenter, Anne E.
    Civelek, Mete
    O'Rourke, Eyleen J.
    PLOS GENETICS, 2021, 17 (09):
  • [49] A Functional Genomic Screen for Evolutionarily Conserved Genes Required for Lifespan and Immunity in Germline-Deficient C. elegans
    Sinha, Amit
    Rae, Robbie
    PLOS ONE, 2014, 9 (08):
  • [50] Reducing Effect of Farnesylquinone on Lipid Mass in C. elegans by Modulating Lipid Metabolism
    Jia, Xihua
    Xu, Manglin
    Yang, Aigang
    Zhao, Yan
    Liu, Dong
    Huang, Jian
    Proksch, Peter
    Lin, Wenhan
    MARINE DRUGS, 2019, 17 (06):